The GLP-1 Revolution: Implications for Health, Inequality and the Food System

Four in 10 people in the UK say they are trying to lose weight most of the time and 66% of the population are currently living with obesity and overweight.

As a result, GLP-1s have perhaps understandably been hailed as one of the most groundbreaking and far-reaching pharmaceutical breakthroughs of recent years.

But despite the optimistic predictions being made for the potential of weight loss drugs to improve the food system, as this report shows if the government is serious about moving from sickness to prevention, expanded treatment must sit alongside stronger action and regulation to improve the food environment and prevent obesity in the first place.